Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (1y) (2012 - 2019)
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (1y) (2012 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
67.94% |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
- |
| Date | Value |
|---|
| Nov 30, 2019 |
79.06% |
| Aug 31, 2019 |
-91.54% |
| May 31, 2019 |
-86.31% |
| Feb 28, 2019 |
-32.80% |
| Nov 30, 2018 |
-345.83% |
| Aug 31, 2018 |
103.79% |
| May 31, 2018 |
-45.10% |
| Feb 28, 2018 |
11.75% |
| Nov 30, 2017 |
-30.20% |
| Aug 31, 2017 |
215.43% |
| May 31, 2017 |
-17.45% |
| Feb 28, 2017 |
-184.94% |
| Nov 30, 2016 |
-169.36% |
| Aug 31, 2016 |
65.97% |
| May 31, 2016 |
-161.76% |
| Feb 29, 2016 |
96.64% |
| Nov 30, 2015 |
259.06% |
| Aug 31, 2015 |
35.86% |
| May 31, 2015 |
131.22% |
| Feb 28, 2015 |
-353.66% |
